Results 91 to 100 of about 19,411 (194)

Grape Pomace as a Source of Phenolics for the Inhibition of Starch Digestion Enzymes: A Comparative Study and Standardization of the Efficacy

Foods
The increase in the incidence of hyperglycemia and diabetes poses the challenge of finding cost-effective natural inhibitors of starch digestion enzymes. Among natural compounds, phenolics have been considered as promising candidates.
Pedapati Siva Charan Sri Harsha, Vera Lavelli   +1 more
doaj   +1 more source

The Effects of Acarbose Treatment on Intimal Hyperplasia in a Rat Carotid Endarterectomy Model of Diet-Induced Insulin Resistance

, 2010
Background: Increased carotid restenosis due to revascularization therapy is associated with insulin resistance. We hypothesize that glucose control using acarbose may attenuate intimal hyperplasia in rat carotid endarterectomy model of diet-induced ...
Danielle N. Campbell, Mohammed M. Moursi, John O. Nyalala, null Shaoke Luo, Aliza T. Brown   +4 more
core   +1 more source

The docked binding mode of acarbose with α-amylase.

The docked binding mode of acarbose with α-amylase.
Li Kong (286966), Zhenzhen Wang (250368), Yue Zhou (71752), Yuxin Chen (126718), Hongguang Tang (17873758), Jinyang Shen (17734526), Caiping Liu (1691287), Jianhui Zhang (450305), Haiyun Jiang (17873755)   +8 more
core   +1 more source

Acarbose effects on vascular stiffness in patients with arterial hypertension and metabolic syndrome

Кардиоваскулярная терапия и профилактика, 2006
Aim. To assess perspectives of pulse wave velocity (PWV) correction during acarbose treatment in patients with impaired glucose tolerance (IGT) and arterial hypertension (AH). Material and methods.
S. V. Nedogoda, V. A. Tsoma, I. N. Barykina, G. V. Mazina, U. A. Brel, T. A. Chalyabi, V. B. Mychka, I. E. Chazova   +7 more
doaj  

SGLT‐2 inhibitors and high‐dose acarbose as potential high‐risk combinations for ketosis and ketoacidosis in Asian patients with T2DM: A case series

Clinical Case Reports
Key Clinical Message High‐dose acarbose may increase the risk of diabetic ketosis/diabetic ketoacidosis in Asian patients on sodium‐glucose cotransporter‐2 inhibitors.
Wei Qiang, Fei Yang, Ling Liu, Ruiqing Dong, Yushi Sun, Ahona Mondal, Hui Guo   +6 more
doaj   +1 more source

Cost Minimization Analysis of Oral Antidiabetic Drugs in Type II Diabetes Mellitus Patiens at Sultan Suriansyah Hospital January-December 2022 Period

Berkala Kedokteran
Diabetes According to WHO (2016) is a serious chronic disease that occurs when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces.
Farah Noor Ain, Saftia Aryzki, Muhammad Mahendra Abdi   +2 more
doaj   +1 more source

Utilizing Acarbose as a Model for Pompe Disease

Pompe Disease is a rare autosomal recessive disorder caused by mutations in the alpha-glucosidase (GAA) gene. These mutations leads to a pathological accumulation of glycogen in the lysosome, thereby impairing lysosomal function. At present, most studies
Humadi, Dania, Alvarnaz, Lydia, Sterling, Felicity   +2 more
core   +1 more source

Acarbose treatment in obesity: a controlled study.

, 1998
Acarbose is an alpha-glucosidase inhibitor which reversibly inhibits oligosaccharidase and disaccharidase at the brush border of the small intestine. The aim of this study was to observe its effectiveness in the treatment of obesity.
Ozgen A.G., Yilmaz C., Tüzün M., Hamulu F., Bayraktar F., Kabalak T.   +5 more
core   +1 more source

When Acarbose Overdose Turns Severe: Managing Hypoglycemia in an Uncommon Scenario

Clinical Case Reports
Acarbose is usually safe, but overdose can trigger severe, life‐threatening hypoglycemia. In cases of unexplained low blood sugar—particularly in patients with psychiatric illness or access to hypoglycemic drugs—acarbose toxicity should be considered ...
Aron Shrestha, Navin Poudel, Kshitiz Acharya, Arjun Chaudhary, Manish Acharya, Santosh Bastola, Bibek Ghimire   +6 more
doaj   +1 more source

Intervention effect of individualized diet nursing combined with acarbose on blood glucose and intestinal flora of patients with type 2 diabetes

Huli yanjiu, 2016
Objective: To probe into the change situation of blood glucose and intestinal flora of T2DM patients who received the treatment of individualized diet nursing combined with acarbose.Methods:A total of 296 T2DM patients who received and cured from ...
沈婷, 陶琼, 王婧, 陈红, 李玲, 何旭梅, 胡波   +6 more
doaj